Aspirin-induced platelet inhibition in patients undergoing cardiac surgery

Platelets

Volumn 18, Issue 7, 2007, Pages 528-534

  Zimmermann, Norbert ^a   Kurt, Muhammed ^b   Winter, Joachim ^b   Gams, Emmeran ^b   Wenzel, Folker ^b   Weber, Artur Aron ^b   Hohlfeld, Thomas ^b  

^a Federal Institute for Drugs and Medical Devices   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Aspirin; Cardiac surgery; Cardiopulmonary bypass

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; THROMBOXANE;

ANTICOAGULANT THERAPY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFECT; HEART SURGERY; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TREATMENT RESPONSE; TURBIDIMETRY;

AORTIC VALVE; ASPIRIN; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; HUMANS; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; THROMBOXANES;

EID: 35649016721     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100701321250     Document Type: Article

References (25)

1. Hyde JA, Chinn JA, Graham TR. Platelets and cardiopulmonary bypass. Perfusion 1998;13:389-407.
2. Moller CH, Steinbruchel DA. Platelet function after coronary artery bypass grafting: Is there a procoagulant activity after off-pump compared with on-pump surgery? Scand Cardiovasc J 2003;37:149-153.
3. Weerasinghe A, Taylor KM. The platelet in cardiopulmonary bypass. Ann Thorac Surg 1998;66:2145-2152.
4. Zimmermann N, Wenk A, Kim U, Kienzle P, Weber AA, Gams E, et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003;108:542-547.
5. Stein PD, Schunemann HJ, Dalen JE, Gutterman D. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: The Seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:600S-608S.
6. Zimmermann N, Roussiekan T, Winter J, Kurt M, Gams E, Wenzel F, Hohlfeld T. Platelet inhibition by aspirin after aortic valve replacement. J Thorac Cardiovasc Surg 2006;131:1392-1393.
7. Heras M, Chesebro JH, Fuster V, Penny WJ, Grill DE, Bailey KR et al. High risk of thromboembolism early after bioprosthetic cardiac valve replacement. J Am Coll Cardiol 1995;25:1111-1119.
8. George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991;324:27-39.
9. Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG. Antithrombotic therapy in valvular heart disease - native and prosthetic. Chest 2004;126:457S-482S.
10. O'Brien JR. "Exhausted" platelets continue to circulate. Lancet 1978;16:1316-1317.
11. Pareti FI, Capitanio A, Mannucci L, Ponticelli C, Mannucci PM. Acquired dysfunction due to the circulation of "exhausted" platelets. Am J Med 1980;69:235-240.
12. Riddle JM, Stein PD, Magilligan DJ Jr, McElroy HH. Evaluation of platelet reactivity in patients with valvular heart disease. J Am Coll Cardiol 1983;1:1381-1384.
13. Goldsmith IR, Blann AD, Patel RL, Lip GY. Plasma fibrinogen, soluble P-selectin, and von Willebrand factor in aortic valve disease: Evidence for abnormal haemorheology, platelet activation, and endothelial dysfunction. Heart 2000;83:577-578.
14. Torfgard KE, Ahlner J. Mechanisms of action of nitrates. Cardiovasc Drugs Ther 1994;8:701-717.
15. Anfossi G, Massucco P, Piretto V, Mularoni E, Cavalot F, Mattiello L, Trovati M. Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: A mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates. Clin Exp Pharmacol Physiol 1995;22:803-811.
16. O'Brien JR, Etherington MD, Brant J, Watkins J. Decreased platelet function in aortic valve stenosis: High shear platelet activation then inactivation. Br Heart J 1995;74:641-644.
17. Vincentelli A, Susen S, Le Tourneau T, Six I, Fabre O, Juthier F et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003;349:343-349.
18. Yoshida K, Tobe S, Kawata M, Yamaguchi M. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. Ann Thorac Surg 2006;81:490-494.
19. Koppensteiner R, Moritz A, Schlick W, Fenzl G, Roedler S, Ehringer H, Wollner E. Blood rheology after cardiac valve replacement with mechanical prostheses or bioprostheses. Am J Cardiol 1991;67:79-83.
20. Benedek IH, Joshi AS, Pieniaszek HJ, King SY, Kornhauser DM. Variability in the pharmacokinetics and pharmacodynamics of low dose aspirin in healthy male volunteers. J Clin Pharmacol 1995;35:1181-1186.
21. Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN, Griffith BP. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006;131:122-130.
22. Freedman JE. The aspirin resistance controversy - clinical entity or platelet heterogeneity? Circulation 2006;113:2865-2867.
23. Hankey GJ, Eikelboom JW. Aspirin resistance (Review). Lancet 2006;367:606-607.
24. Weber AA, Przytulski B, Schanz A, Hohlfeld T, Schrör K. Towards a definition of aspirin resistance: A typological approach. Platelets 2002;13:37-40.
25. Zimmermann N, Kurt M, Wenk A, Winter J, Gams E, Hohlfeld T. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting? Eur J Cardiothorac Surg 2005;27:606-610.